Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 20Unknown 16Terminated 3Active not recruiting 3Withdrawn 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Pain 1Ovarian Neoplasms 1Neoplasms 1Multi-organ Metastatic Colorectal Cancer 1Lymphatic Metastasis 1Cholangiocarcinoma 1Carcinoma, Medullary 1Breast Neoplasms 1Agnosia 1

Interventions

durvalumab 18Bevacizumab 17atezolizumab 13lenvatinib 10Magnetic Resonance Spectroscopy 10tremelimumab 8Nivolumab 8pembrolizumab 7Sorafenib 6Specimen Handling 5camrelizumab 4cabozantinib 4Immunoglobulin G 4Disulfides 4sintilimab 3apatinib 3X-Rays 3Radiotherapy 3Radiofrequency Ablation 3Radiation 3Hepatectomy 3E-7386 3Doxorubicin 3Cyclophosphamide 3tislelizumab 2relatlimab 2dostarlimab 2budigalimab 2Standard of Care 2Simvastatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Hepatocellular × Radiofrequency Ablation × Clear all
NCT05666271 2026-04-13

Radiofrequency Ablation for Hepatocellular Carcinoma Using Octopus MP Electrodes

Seoul National University Hospital

Active not recruiting
76 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06682377 2024-11-12

SM-OCT-01

Seoul National University Hospital

Phase NA Active not recruiting
159 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05433701 2023-08-18

Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC

Asan Medical Center

Phase NA Active not recruiting
178 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡